Synthetic Hydrogels Incorporating Hydrolytic/Nonhydrolytic Macromer Ratios Exhibit Improved Tunability of In Vivo Degradation and Immune Responses
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202502475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Michael D Hunckler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 801 Ferst Dr NW, Atlanta, GA, 30332, USA. Hauptthemen laut MEDLINE: Hydrogels. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Juvenile Diabetes Research Foundation International, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Proteolytically degradable hydrogels are widely used as delivery carriers in regenerative medicine. However, the in vivo degradation rate of these materials is difficult to control because of site‐specific enzymatic activity, implant design, and disease state, impairing tissue regeneration. Hydrogels with crosslinks that degrade hydrolytically offer an alternate route to tune in vivo degradation profile. In this study, a synthetic 4‐arm maleimide‐terminated poly(ethylene glycol) (PEG‐4MAL) hydrogel system that combines hydrolytic ester‐linked PEG‐4MAL (PEG‐4eMAL) macromer with nondegradable amide‐linked PEG‐4MAL (PEG‐4aMAL) macromer in various stoichiometric ratios to tune the degradability rate is engineered. The macromers are crosslinked with dithiothreitol (DTT) via thiol‐maleimide click reaction. Rheological analysis shows that a family of PEG‐4eMAL/PEG‐4aMAL hydrogels has equivalent mechanical properties, but increasing the PEG‐4eMAL content increases the rate of degradation in vitro and in vivo. PEG‐4eMAL/PEG‐4aMAL hydrogels support high viability of encapsulated human cells. Notably, the ratio of PEG‐4eMAL/PEG‐4aMAL modulates local immune cell recruitment when implanted in the subcutaneous space. These results establish the use of PEG‐4eMAL/PEG‐4aMAL hydrogels as a hydrolytically degradable platform to tune in vivo degradation and immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 801 Ferst Dr NW, Atlanta, GA, 30332, USA.
- Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, 315 Ferst Dr NW, Atlanta, GA, 30332, USA.
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Dr NW, Atlanta, GA, 30332, USA.
- Emory University School of Medicine, Emory University, 100 Woodruff Cir, Atlanta, GA, 30322, USA.
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Dr NW, Atlanta, GA, 30332, USA.
ORCID-Profile: Andrés J García
Förderung
- NIDDK NIH HHS
- Juvenile Diabetes Research Foundation International
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Hunckler, M. D., Kioulaphides, S., Martin, K. E., Torres, A. L., Barber, G. F., Linderman, S. W., Schneider, R. S., & García, A. J. (2026). Synthetic Hydrogels Incorporating Hydrolytic/Nonhydrolytic Macromer Ratios Exhibit Improved Tunability of In Vivo Degradation and Immune Responses. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502475
Vancouver
Hunckler MD, Kioulaphides S, Martin KE, Torres AL, Barber GF, Linderman SW, et al. Synthetic Hydrogels Incorporating Hydrolytic/Nonhydrolytic Macromer Ratios Exhibit Improved Tunability of In Vivo Degradation and Immune Responses. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502475
BibTeX
@article{Hunckler2026,
author = {Hunckler, Michael D and Kioulaphides, Sophia and Martin, Karen E and Torres, Angelica L and Barber, Graham F and Linderman, Stephen W and Schneider, Rebecca S and García, Andrés J},
title = {Synthetic Hydrogels Incorporating Hydrolytic/Nonhydrolytic Macromer Ratios Exhibit Improved Tunability of In Vivo Degradation and Immune Responses},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202502475}
}
EUVIMED